Imagery Rescripting with or without preceding Cognitive Restructuring: a randomized clinical trial

Imagery Rescripting with or without preceding Cognitive Restructuring: a randomized clinical trial - Imagery Rescripting with or without preceding Cognitive Restructuring

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46092

Enrollment

Registered

2016-06-01

Start date

2016-10-14

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stemmingsstoornissen en angststoornissen depression fear problem problems with personality

Interventions

This research project will employ the following conditions focused on the application of ImRs on an aversive childhood memory 1) CR preceding ImRs, 2) therapist attention placebo and ImRs 3) double

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Meet the diagnostic criteria of a one or more diagnoses according to the DSM IV either/and on axis I (clinical disorders) and II (personality disorders) - Free of medication or at least 2 months of stably set medication and maintaining the same dosage during participation of this study - Age between 18 and 65 years - IQ above 80 - Able to read and write in Dutch

Exclusion criteria

Exclusion criteria: - Meet the diagnostic criteria of posttraumatic stress disorder an autism spectrum disorder or psychotic disorder accordingaccording to the DSM IV - Suicidality or other self-damaging behaviour or damaging behaviour towards others - Habitual use of benzodiazepines. In case of incidental use of benzodiazepines or betablockers participants are asked to refrain from this medication at the testing day. Participants using SSRI*s, TCA*s, or antipsychotic medication are asked to keep their medication stable till after the one week follow-up. - Treatment experience with CBT - Treatment experience with ImRs

Design outcomes

Primary

Measure	Time frame
The difference between the encapsulated belief scores at pre-test, post-test and one week follow up are the primary outcome measures. A scale ranging from 0 (not at all) to 100 (extremely) is used.	—

Secondary

Measure	Time frame
Change in vividness and distress of the aversive childhood memory addressed is measured on a scale ranging 0 to 100. To examine the reduction of overall symptomatology The Brief Symptom Inventory (BSI) is included as a secondary parameter. To check whether different emotional states are triggered throughout the study the Modified Differential Emotions Scale (mDES) will be used. During the one-week-follow-up the experience of CR and ImRs is investigated with a qualitative interview.	—

Measure

Time frame

Change in vividness and distress of the aversive childhood memory addressed is measured on a scale ranging 0 to 100. To examine the reduction of overall symptomatology The Brief Symptom Inventory (BSI) is included as a secondary parameter. To check whether different emotional states are triggered throughout the study the Modified Differential Emotions Scale (mDES) will be used. During the one-week-follow-up the experience of CR and ImRs is investigated with a qualitative interview.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)